Ekso Bionics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $4,227 | $2,057 | $3,375 | $5,090 |
Gross Profit | 2,549 | 819 | 1,806 | 2,714 |
EBITDA | -1,036 | -2,267 | -3,440 | -2,956 |
EBIT | -1,403 | -2,644 | -2,963 | -3,354 |
Net Income | -1,421 | -2,709 | -2,891 | -3,413 |
Net Change In Cash | 4,227 | 2,057 | 3,375 | 5,090 |
Free Cash Flow | -2,011 | -3,444 | -1,965 | -1,454 |
Cash | 2,722 | 5,242 | 8,054 | 6,493 |
Basic Shares | 2,616 | 2,180 | 25,393 | 24,640 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $17,925 | $18,279 | $12,912 | $11,246 |
Gross Profit | 9,511 | 9,079 | 6,214 | 6,749 |
EBITDA | -9,453 | -13,198 | -14,037 | -9,090 |
EBIT | -11,061 | -14,896 | -14,924 | -9,651 |
Net Income | -11,330 | -15,198 | -15,080 | -9,764 |
Net Change In Cash | 17,925 | 18,279 | 12,912 | 11,246 |
Free Cash Flow | -9,883 | -12,211 | -14,882 | -11,215 |
Cash | 6,493 | 8,638 | 20,525 | 40,406 |
Basic Shares | 20,161 | 13,867 | 12,962 | 12,269 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.54 |
2025-06-30 | -$1.24 |
2025-03-31 | -$0.12 |
2024-12-31 | -$0.14 |
